Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sikorski

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Science Translational Medicine|April 7, 2010
Parallel paths to predictive biomarkers in oncology: Uncoupling of emergent biomarker development and phase III trial executionRobert Sikorski, Bin Yao
Science Translational Medicine|June 4, 2010
Visualizing the landscape of selection biomarkers in current phase III oncology clinical trialsRobert Sikorski, Bin Yao
Critical Care Medicine|August 21, 2010
Changing paradigms in surgical resuscitationYvette Fouche, Robert Sikorski, Richard P Dutton
Pain Research & Management|September 11, 2015
Opioid use among same-day surgery patients: Prevalence, management and outcomesJennifer Lc Wilson, Patricia A Poulin, Robert Sikorski, et al.
The Cochrane Database of Systematic Reviews|December 17, 2015
Helicopter emergency medical services for adults with major traumaSamuel M Galvagno, Robert Sikorski, Jon M Hirshon, et al.
The Journal of Rheumatology|August 3, 2017
Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in DenmarkVera Ehrenstein, Søren L Andersen, Ibrahim Qazi, et al.
Breast Cancer Research and Treatment|August 9, 2012
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancerRichard H De Boer, Dusan Kotasek, Shane White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerRafael G Amado, Michael Wolf, Marc Peeters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancerRafael G Amado, Michael Wolf, Marc Peeters, et al.
Transfusion|February 12, 2019
Hemostatic properties of cold-stored whole blood leukoreduced using a platelet-sparing versus a non-platelet-sparing filterKathy Haddaway, Evan M Bloch, Aaron A R Tobian, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Science Translational Medicine|April 7, 2010
Parallel paths to predictive biomarkers in oncology: Uncoupling of emergent biomarker development and phase III trial executionRobert Sikorski, Bin Yao
Science Translational Medicine|June 4, 2010
Visualizing the landscape of selection biomarkers in current phase III oncology clinical trialsRobert Sikorski, Bin Yao
Critical Care Medicine|August 21, 2010
Changing paradigms in surgical resuscitationYvette Fouche, Robert Sikorski, Richard P Dutton
Pain Research & Management|September 11, 2015
Opioid use among same-day surgery patients: Prevalence, management and outcomesJennifer Lc Wilson, Patricia A Poulin, Robert Sikorski, et al.
The Cochrane Database of Systematic Reviews|December 17, 2015
Helicopter emergency medical services for adults with major traumaSamuel M Galvagno, Robert Sikorski, Jon M Hirshon, et al.
The Journal of Rheumatology|August 3, 2017
Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in DenmarkVera Ehrenstein, Søren L Andersen, Ibrahim Qazi, et al.
Breast Cancer Research and Treatment|August 9, 2012
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancerRichard H De Boer, Dusan Kotasek, Shane White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerRafael G Amado, Michael Wolf, Marc Peeters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancerRafael G Amado, Michael Wolf, Marc Peeters, et al.
Transfusion|February 12, 2019
Hemostatic properties of cold-stored whole blood leukoreduced using a platelet-sparing versus a non-platelet-sparing filterKathy Haddaway, Evan M Bloch, Aaron A R Tobian, et al.
Pageof 2